Bransch creening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies

Journal of Digestive Diseases

Volumn 8, Issue 1, 2007, Pages 15-22

  Cao, Qin ^a   Ran, Zhi Hua ^a   Xiao, Shu Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atrophic gastritis; Gastric cancer; Gastrin 17; Helicobacter pylori antibodies; Pepsinogen

Indexed keywords

EID: 43649108741     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1443-9573.2007.00271.x     Document Type: Article

References (28)

1. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 2003; 14 (Suppl. 2): ii31-6.
2. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173-7.
3. Nishizawa M, Shiga T, Hayashi G. Comparison between the serum pepsinogen test method and the conventional photofluorography. A randomized controlled study. In: Miki K, ed. Pepsinogen Test Method. Tokyo: Igaku-shoin, 1998; 56-62 (in Japanese).
4. Sipponen P, Ranta P, Helske T et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002; 37: 785-91.
5. Sipponen P, Harkonen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002; 48: 505-15.
6. Vaananen H, Vauhkonen M, Helske T et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15: 885-91.
7. Yoshihara M, Sumii K, Haruma K et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998; 93: 1090-6.
8. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003; 98: 735-9.
9. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44: 693-7.
10. Kikuchi S, Kurosawa M, Sakiyama T et al. Long-term effect of Helicobacter pylori infection on serum pepsinogens. Jpn J Cancer Res 2000; 9: 474-6.
11. Nameketa T, Miki K, Kimmey M et al. Chronic atrophic gastritis and Helicobacter pylori infection among Japanese- Americans in Seattle. Am J Epidemiol 2000; 151: 820-30.
12. Forman D. Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst 1991; 83: 1702-3.
13. Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
14. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6.
15. Kokkola A, Rautelin H, Puolakkainen P et al. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol 2000; 35: 138-41.
16. Samloff IM. Pepsinogens I and II. Purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982; 82: 26-33.
17. Sitas F, Smallwood R, Jewell D et al. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol Biomarkers Prev 1993; 2: 119-23.
18. Wu KC, Li HT, Qiao TD et al. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Chin J Digestive Dis 2004; 5: 22-7.
19. Ito M, Harama K, Kamada T et al. Helicobacter pylori eradication therapy improved atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2003; 16: 1449-56.
20. Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogens secretion from isolated human-peptic cells. Gut 2002; 50: 13-8.
21. Jin N, Shen MC. The expression of pepsinogen in gastric cancer and precancerous tissues. Chin J Pathol 1991; 2: 84-6.
22. Ohata H, Oka M, Yanaoka K et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci 2005; 96: 713-20.
23. Du J, Wang XQ. The biological activity and the signal transduction pathway of gastrin. Prog Anat Sci 2003; 9: 347-52.
24. Xiao SD, Jiang SJ, Shi Y et al. Pernicious anemia and type A atrophic gastritis in the Chinese. Chin Med J 1990; 103: 192-6.
25. Diane H, Basabi R, Jessica R et al. Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1. Am J Physiol Gastrointest Liver Physiol 2003; 285: G217-22.
26. Wang TC, Dangler CA, Chen D et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118: 36-47.
27. Cheng ZM, Li L, Chen LN. The values of combined detection of pepsinogen I, II and gastrin in gastric cancer diagnosis. Chin J Dig Endosc 2002; 19: 32-4.
28. Nduduba DA, Rotimt O, Otegbeye FM. Helicobacter pylori and the pathogenesis of gastroduodenal disease: implications for the management of peptic ulcer disease. Niger Postgrad Med J 2005; 12: 289-98.